| Opticap XL 2 | Opticap XL 4 | Opticap XL 5 | Opticap XL 10 |
| Filtration Area, m2 | 0.1 | 0.21 | 0.32 | 0.65 |
| Materials of Construction |
| Filter media | Hydrophobic PTFE |
| Supports | Polypropylene |
| Structural components | Polypropylene |
| Vent O-ring | Silicone |
| Vent/Drain | 1/4 in. hose barb with double O-ring seal |
| Integrity Test |
| Bubble Point | ≥1100 mbar (16 psig) nitrogen with 70//30 % IPA/water |
| Diffusion | — | ≤9 mL/min @ 965 mbar (14 psig) in 70//30 % IPA/water | ≤12 mL/min @ 965 mbar (14 psig) in 70//30 % IPA/water | ≤24 mL/min @ 965 mbar (14 psig) in 70//30 % IPA/water |
| HydroCorr Test | ≤0.12 mL/min @ 2.6 bar (38 psig) | ≤0.25 mL/min @ 2.6 bar (38 psig) | ≤0.38 mL/min @ 2.6 bar (38 psig) | ≤0.75 mL/min @ 2.6 bar (38 psig) |
| Maximum Inlet Pressure, bar (psid) | 5.5 (80) @ 23 °C; 2.8 (40) @ 60 °C; 1.0 (15) @ 80 °C |
| Maximum Differential Pressure, bar (psid) | Forward: 5.5 (80) @ 25 °C; 1.0 (15) @ 80 °C. Reverse: 4.1 (60) @ 25 °C, intermittent |
| NVR Gravimetric Extractables | ≤15 mg after autoclaving and a 24 hour soak in 70//30 % IPA/water | ≤15 mg after autoclaving and a 24 hour soak in 70//30 % IPA/water | ≤28 mg after autoclaving and a 24 hour soak in 70//30 % IPA/water | ≤45 mg after autoclaving and a 24 hour soak in 70//30 % IPA/water |
| Bacterial Endotoxins | Aqueous extraction contains <0.5 EU/mL as determined by the LAL test |
| Bacterial Retention | Quantitative retention of 107 CFU/cm2 Brevundimonas diminuta ATCC® 19146 per ASTM methodology. |
| Sterilization | 30 autoclave cycles of 30 min @ 135 °C; not in-line steam sterilizable |
| Toxicity | Non-toxic per MEM elution ISO® 10993-5 |
| Good Manufacturing Practices | These products are manufactured in a facility which adheres to FDA Device Good Manufacturing Practices. |
| Non-Fiber Releasing | Component materials meet the "non-fiber releasing" criteria as defined in 21 CFR 210.3 (b) (6). |
| European Pressure Equipment Directive | Millipore Corporation certifies that this product complies with the European Pressure Equipment Directive, 97/23/EC of 29 May 1997. This product has been classified under Article 3 § 3 of the Pressure Vessel Directive. It has been designed and manufactured in accordance with sound engineering practice to ensure safe use. In compliance with Article 3 § 3 of this Pressure Equipment Directive, this product does not bear the CE mark. |
| Viral Retention | Rated for aerosol retention of a total challenge of 108–1010 plaque forming units of ΦX-174 virus particles at 85 Nm3/h (50 SCFM) per cartridge. |
| Bacterial Aerosol Growth | Retains Brevundimonas diminuta liquid aerosol for 21 days at a minimum challenge of 107 CFU/cm2. |